tykhr
sign in
free sign up
Nymox Pharmaceutical Corporation
Biotechnology
Healthcare
NYMX
85.55 M shares
NASDAQ US
traded
17 May 2022
listed
yes
open
1.37
52 week high
2.65
high
1.38
52 week low
1.32
low
1.37
growth
-9.87 %
previous Close
1.35
P/E ratio
market cap
114 M
div yield
0
usd
Dec 2021
qoq
revenue
0.00 %
net incoming
-2.81 M
14.80 %
eps
16.75 %
eps surprise
0.00 %
net profit margin
-281000000.00 %
0.00 %
operating incoming
-2.77 M
16.08 %
net change in cash
-2.31 M
24.42 %
cash on hand
830 K
-73.58 %
cost of revenue
0.00 %
top